Clinical Performance of Nobel N1 System

This study aims to evaluate the survival and stability of the Nobel N1 dental implant and its accompanying crown over a one-year period when the crown is placed either 6 or 12 weeks after implant placement. The Nobel N1 implant is an FDA-approved, newly designed implant featuring an innovative surgical placement protocol intended to minimize bone trauma, promote faster integration, and potentially allow for the placement of final crowns earlier-at 6 weeks instead of the traditional 4 to 5 months. This study will enroll adult participants who are missing a single tooth in the back of the mouth.

Inclusion criteria

• Males and females, age 18 or older

• Can provide an Informed Consent in English.
• Absence of a single posterior tooth in mandible or maxilla with presence of natural neighboring teeth (except for second molar which only requires presence of first molar)
• Presence of antagonist teeth
• Possibility and will for an immediate restoration.
• Systemic health recorded as an American Society of Anesthesiologists (ASA) I or II

Exclusion criteria

• · Unavailability to attend the follow-up visits.

• A systemic contraindication for oral surgical procedures; ASA III or IV.
• Pregnancy or nursing on screening or before the surgical procedure.
• Diseases that could alter healing or bone metabolism (uncontrolled diabetes, diagnostic osteoporosis, etc.),
• Taking medications that are altering healing or bone metabolism (bisphosphonates, long-time corticosteroids intake, RANK inhibitors, etc.)
• Alcohol or drug abuse.
• Current heavy smoking behavior (≥10 cigarettes/day).
• Radiation therapy to the head or neck region.
• Pathology in the implant planned sites that prevent implant placement.
• Current diagnosis of Diabetes, which is uncontrolled (>7 HbA1C).
• Need for sinus lift or vertical bone augmentation
• Previously failed implant site